<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03597373</url>
  </required_header>
  <id_info>
    <org_study_id>Reintubation</org_study_id>
    <nct_id>NCT03597373</nct_id>
  </id_info>
  <brief_title>Variables Predicting Reintubation After Thymectomy in Patients With Myasthenia Gravis</brief_title>
  <official_title>Variables Predicting Reintubation After Thymectomy in Patients With Myasthenia Gravis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>First Affiliated Hospital, Sun Yat-Sen University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>First Affiliated Hospital, Sun Yat-Sen University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Myasthenia gravis (MG) is an autoimmune disease that is characterized by muscle weakness and&#xD;
      fatigue. The role of the thymus in MG has been suggested by the evidence that 10% to 15% of&#xD;
      patients present with a thymoma and at least 60% with thymus hyperplasia or&#xD;
      dysplasia.Beneficial effects of thymectomy in patients with MG have been described in 40% to&#xD;
      90%.Few studies have looked at the incidence of reintubation (not just within 24 hours after&#xD;
      extubation), the factors associated with reintubation, and patient outcome.&#xD;
&#xD;
      Premature extubation may lead to hypercarbia, hypoxemia, pulmonary hypertension, right heart&#xD;
      failure, and myocardial ischemia. Additionally, it subjects the patient to the physical risks&#xD;
      of reintubation, including esophageal intubation, laryngeal trauma, and pulmonary aspiration.&#xD;
      The purpose of the present study was to determine the incidence of reintubation, the&#xD;
      variables associated with reintubation, and patient outcome&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Inclusion was based on the availability of all the following possible predictive&#xD;
      pre-operative variables: age, gender, weight, height, body mass index, diabetes, creatinine,&#xD;
      duration of MG, severity of MG (based on Osserman's classification), pathological type of MG,&#xD;
      history of myasthenic crisis, dose of pyridostigmine, use of a steroid hormone, and use of an&#xD;
      immunosuppressant.operative variables: postoperative pulmonary infection, total duration of&#xD;
      hospital stay, duration of ICU stay, and duration of postoperative hospital stay. Variables&#xD;
      were collected by research assistants and maintained in a computer database.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date type="Actual">January 1, 2017</start_date>
  <completion_date type="Anticipated">January 1, 2019</completion_date>
  <primary_completion_date type="Anticipated">January 1, 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Risk Factors for Reintubation</measure>
    <time_frame>an average of 30 days</time_frame>
    <description>the reintubation rate was analyzed with logistic regression</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">99</enrollment>
  <condition>Myasthenia Gravis</condition>
  <arm_group>
    <arm_group_label>reintubation</arm_group_label>
    <description>Reestablish of invasive mechanical ventilation</description>
  </arm_group>
  <arm_group>
    <arm_group_label>not reintubation</arm_group_label>
    <description>Favourable respiratory function</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>reintubation</intervention_name>
    <description>Reintubation was defied by the reinstitution of invasive mechanical ventilation following extubation at any time</description>
    <arm_group_label>not reintubation</arm_group_label>
    <arm_group_label>reintubation</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        patients with myasthenia gravis undergoing thymectomy&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  younger than 75 years&#xD;
&#xD;
          -  absence of heart failure as the primary indication for mechanical ventilation •Acute&#xD;
             Physiology and Chronic Health Evaluation (APACHE) II score less than 12 points on day&#xD;
             of extubation&#xD;
&#xD;
          -  body mass index less than 30&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        •preoperative moderate-to-severe chronic obstructive pulmonary disease&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Genglong Liu</last_name>
    <role>Principal Investigator</role>
    <affiliation>First Affiliated Hospital, Sun Yat-Sen University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Genglong Liu</last_name>
    <phone>+8615626405844</phone>
    <email>lglong3@mail2.sysu.edu.cn</email>
  </overall_contact>
  <location>
    <facility>
      <name>Genglong Liu</name>
      <address>
        <city>Guangzhou</city>
        <state>Guangdong</state>
        <zip>510080</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Genglong Liu, MD</last_name>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>July 2018</verification_date>
  <study_first_submitted>July 13, 2018</study_first_submitted>
  <study_first_submitted_qc>July 20, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">July 24, 2018</study_first_posted>
  <last_update_submitted>July 20, 2018</last_update_submitted>
  <last_update_submitted_qc>July 20, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">July 24, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>First Affiliated Hospital, Sun Yat-Sen University</investigator_affiliation>
    <investigator_full_name>GengLong Liu</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>Prediction</keyword>
  <keyword>Myasthenia gravis</keyword>
  <keyword>Reintubation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Myasthenia Gravis</mesh_term>
    <mesh_term>Muscle Weakness</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

